The C3 Prize is a challenge aimed at inspiring non-medicine and non-treatment innovation to change cancer care for patients and their loved ones. The cancer care continuum encompasses all phases of care during illness, from diagnosis to the end of life.1
Three prizes will be awarded as follows: one $50,000 grant and two $25,000 grants. These grants are meant to help winners further develop their ideas and bring them to life. Additionally, Astellas may also, at its sole discretion, assist winners in developing their idea. The three grant winners will also receive a one year membership to MATTER, the Chicago-based healthcare technology incubator and community hub.
The Astellas Oncology C3 Prize is subject to all applicable federal, state, provincial and local laws and regulations. Astellas Pharma reserves the right to change, alter, or modify these rules and/or dates at any time without notice.